Table 2 Univariate and multivariate survival analyses of OS and DFS in HNSCC patients.
Variables | Disease free survival | Overall survival | ||||
|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||
p value | HR (95% CI) | p value | p value | HR (95% CI) | p value | |
HPV status | ||||||
Negative | 0.027 | 1 | 0.037 | 0.132 | ||
Positive | 0.566 (0.331–0.967) | |||||
Primary lesion | ||||||
Hypopharynx | 0.158 | 0.140 | ||||
Larynx | ||||||
Oral cavity | ||||||
Oropharynx | ||||||
T factor | ||||||
T0-2 | 0.001 | 1 | 0.132 | 0.0002 | 1 | 0.016 |
T3-4 | 1.474 (0.889–2.444) | 1.839 (1.118–3.026) | ||||
N factor | ||||||
Negative | 0.06 | 0.037 | 1 | 0.217 | ||
Positive | 1.267 (0.870–1.846) | |||||
M factor | ||||||
M0 | 0.26 | 0.001 | 1 | 0.0005 | ||
M1 | 6.263 (2.215–17.707) | |||||
TNM stage | ||||||
I–II | 0.009 | 1 | 0.254 | 0.009 | 1 | 0.483 |
III–IV | 1.457 (0.763–2.782) | 0.788 (0.405–1.534) | ||||
Immune signature | ||||||
Cold | 0.320 | 0.005 | 1 | |||
Lymphocyte | 0.362 (0.172–0.763) | 0.008 | ||||
Myeloid/DC | 1.077 (0.780–1.486) | 0.654 | ||||